Press Release
May 22 2025
FORE Biotherapeutics Raises $38 Million in Series D-2 Financing for the Continued Advancement of Plixorafenib
Read more
Press Release
May 27 2025
FORE Biotherapeutics to Participate in the Jefferies Global Healthcare Conference
Read more
Press Release
Apr 30 2025
FORE Biotherapeutics to Present Plixorafenib Abstract at the 2025 American Society of Clinical Oncology Annual Meeting
Read more
Press Release
Apr 25 2025
FORE Biotherapeutics Presents New Plixorafenib Results at AACR 2025 Demonstrating Pharmacodynamic Effect in Clinical Tumor Biopsies and Decreased V600E Mutant Allele Frequency in ctDNA of 85% of Patients
Read more
Press Release
Mar 31 2025
FORE Biotherapeutics to Present Two Plixorafenib Abstracts at the American Association for Cancer Research Annual Meeting 2025
Read more
Press Release
Feb 13 2025
FORE Biotherapeutics to Participate in the Raymond James Private Biotech Symposium
Read more
Press Release
Jan 09 2025
FORE Biotherapeutics Highlights Recent Pipeline Achievements for its Targeted-Oncology Program and Provides Strategic Objectives for 2025
Read more
Press Release
Dec 19 2024
FORE Biotherapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Read more
Press Release
Dec 05 2024
FORE Biotherapeutics to Participate in the Wells Fargo Virtual Private Biotech Symposium
Read more
Press Release
Nov 07 2024
FORE Biotherapeutics to Participate in Upcoming Investor Conferences
Read more